To improve Medicare provider and supplier enrollment data transparency, in 2023, the Centers for Medicare & Medicaid Services publicly released detailed ownership data, including data on change of ownership transactions, for Medicare-enrolled hospices. This brief presents a descriptive analysis of hospice agency changes of ownership nationally between 2018 and 2022.
Health & Health Care
ASPE produces health policy research with a focus on equity, coverage, and access. Find resources related to a broad range of topics, including the uninsured population, vaccine hesitancy, Medicaid/CHIP, Medicare, the federal marketplace (HealthCare.gov), telehealth, health care delivery, underserved areas, delivery system transformation, health outcomes, and social determinants of health.
Noteworthy Resources and Reports
Vaccine Hesitancy for COVID-19: State, County, and Local Estimates
To support state and local communication and outreach efforts, ASPE developed state, county, and sub-state level predictions of hesitancy rates using the most recently available federal survey data. Explore the interactive map and other resources.
Topic Areas
Reports
Displaying 31 - 40 of 1584. 10 per page. Page 4.
Advanced SearchASPE Issue Brief
Hospice Agency Changes of Ownership: An Analysis of Publicly Available Ownership Issue Brief
ASPE Issue Brief
Inflation Reduction Act Research Series: Projecting the Impact of the $2,000 Part D Out-Of-Pocket Cap for Medicare Part D Enrollees with High Prescription Drug Spending
The Inflation Reduction Act includes many provisions that aim to reduce out-of-pocket spending for prescription drugs covered under Medicare Part D. In 2024, cost-sharing in the final phase of the Part D benefit, the catastrophic coverage phase, was eliminated.
Report to Congress
Children's Interagency Coordinating Council (CICC) FY 2024 Report to Congress
Congress has directed HHS to operate the Children’s Interagency Coordinating Council (CICC). The CICC is charged with fostering greater coordination and transparency on child policy across federal agencies and examining a broad array of cross-cutting issues affecting child poverty and child well-being.
Report
Combating Antimicrobial Resistance During the COVID-19 Pandemic: Perceived Risks and Protective Practices
KEY POINTS
Report
Barriers to Attention-Deficit/Hyperactivity Disorder Diagnosis in Adults
Attention-deficit/hyperactivity disorder (ADHD) diagnosis and treatment among adults in the United States have increased over the past few decades. However, there are sex, racial, and ethnic disparities in diagnosis and treatment, and underdiagnosis persists.
ASPE Data Point
Beyond Market Concentration: Using Social Network Analysis to Explore Complex Ownership Structures of Nursing Homes Data Point
CMS has actively worked to enhance ownership transparency in the nursing home industry through a series of data releases. This brief utilizes data from these new CMS initiatives to explore ownership and market structures of nursing homes, providing insights into the complexity and dynamics of nursing home ownership.
Report
Implementation of Mobile Medication Units: Findings from a Qualitative Study
In light of the continuing opioid epidemic in the United States, DEA lifted a moratorium on approvals of new mobile medication units (MMUs) to increase access to OTPs. The new DEA guidance also authorized OTPs to add a “mobile component” to their existing registration, eliminating the separate registration requirement for MMUs.
ASPE Issue Brief
Use of Contract Staff in Nursing Homes Remains High After the COVID-19 Pandemic
Over one million Americans rely on nursing homes for care, yet nursing homes face challenges in recruiting and retaining staff. Nursing homes rely on registered nurses (RNs), licensed practical nurses (LPNs), and nursing assistants (NAs) to provide care, but staff shortages that increased during the COVID-19 pandemic have persisted.
ASPE Issue Brief, Report
New Estimates of the Cost of Preventive Vaccine Development and Potential Implications from the COVID-19 Pandemic
The ASPE issue brief examines the research and development cost and duration associated with bringing novel vaccines to the U.S. market. The results indicate that bringing a novel vaccine to the U.S. market costs an estimated $886.8 million on average, and its development process lasts 10 years.
ASPE Issue Brief
Health Insurance Coverage and Healthcare Access from 2021-2024
This Issue Brief investigates how health insurance coverage, as well as healthcare access and affordability, has changed in recent years, with an emphasis on policies implemented from 2021 to 2024. Over 300 million Americans now have health insurance coverage. The U.S. uninsured rate has fallen significantly over the past four years.